Literature DB >> 6954937

Phaeochromocytoma and pregnancy--an updated appraisal.

J G Schenker, M Granat.   

Abstract

Phaeochromocytoma in pregnancy carries a considerable risk to the mother and is even more dangerous to the fetus. It should, therefore, be kept in mind as a possible cause of hypertension in pregnancy and appropriate laboratory tests undertaken. The data presented in the literature indicate that the early diagnosis of phaeochromocytoma in pregnancy decreases maternal mortality markedly and fetal mortality less significantly. Diagnostic measures to localize the tumour before delivery are limited; radiation exposure to the fetus will be minimized by the adjunctive use of ultrasound and CAT scanning. If the diagnosis is made before 20-24 weeks, the tumour should be excised without delay and pregnancy interrupted or allowed to continue, depending on circumstances. After the 24th week, the pregnancy should usually be continued under adequate adrenergic blockade until fetal maturity is achieved. Labour and vaginal delivery should generally be avoided. Caesarean section and careful removal of the tumour at the same time are recommended.

Entities:  

Mesh:

Year:  1982        PMID: 6954937     DOI: 10.1111/j.1479-828x.1982.tb01388.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  16 in total

Review 1.  Diagnosis and management of pheochromocytoma during pregnancy.

Authors:  M Mannelli; D Bemporad
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

2.  Phaeochromocytoma presenting in pregnancy.

Authors:  D Mulcahy; W F O'Dwyer; M Carmody; A Walsh; J O'Callaghan; P J Garrett
Journal:  Ir J Med Sci       Date:  1984-11       Impact factor: 1.568

3.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

4.  Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy.

Authors:  M F James; K R Huddle; A D Owen; B W van der Veen
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

5.  Unusual association of adrenal pheochromocytoma and para-aortic neurofibroma in pregnancy.

Authors:  A Moretti; M Minuto; P Berti; G P Bernini; M Mannelli; P Miccoli
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

6.  Pheochromocytoma and sub-clinical Cushing's syndrome during pregnancy: diagnosis, medical pre-treatment and cure by laparoscopic unilateral adrenalectomy.

Authors:  G Finkenstedt; R W Gasser; G Höfle; K Lhotta; D Kölle; A Gschwendtner; G Janetschek
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

7.  Caesarean section and phaeochromocytoma resection in a patient with Von Hippel Lindau disease.

Authors:  D Joffe; R Robbins; A Benjamin
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

Review 8.  Pheochromocytoma-induced myocardial infarction in pregnancy. A case report and literature review.

Authors:  C R Jessurun; K Adam; K J Moise; S Wilansky
Journal:  Tex Heart Inst J       Date:  1993

Review 9.  Endocrine causes of hypertension in pregnancy.

Authors:  Alison H Affinati; Richard J Auchus
Journal:  Gland Surg       Date:  2020-02

10.  Paraganglioma presenting as hypertension during pregnancy, proteinuria, thrombocytosis, and diabetes mellitus: a case report.

Authors:  Ramjan Sanas Mohamed; Charles Naveenan Antonypillai; Harishanthi Mahendran
Journal:  J Med Case Rep       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.